English

SINOVAC BIOTECH LTD

EDGAR

SVA Report (type unavailable) · filed 2026-08-17

Annual consolidated revenue for 2025: about USD 386M, using the latest reported figures. The previous period, 2024, was about USD 361.4M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest fiscal year

Revenue

386 million USD

2025 · USD

Exact inputs and evidence

Revenue: 386013000 USD Source

Operating margin

-126.97%

2025 · %

Exact inputs and evidence

Operating Income: -490130000 USD Source
Revenue: 386013000 USD Source

Operating cash flow

-512 million USD

2025 · USD

Exact inputs and evidence

Operating Cash Flow: -512184000 USD Source

Free cash flow

-561 million USD

2025 · USD

Exact inputs and evidence

Operating Cash Flow: -512184000 USD Source
Capital Expenditure: 48917000 USD Source

Cash and cash equivalents: 488 million USD 2025-12-31 Source
Exact value

488248000 USD
Long-term debt including current maturities: 495 million USD 2025-12-31 Source
Exact value

494858000 USD
Shares outstanding: 71.9 million shares 2025-12-31 Source
Exact value

71860702 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

71860702 shares · 2024-12-31· Source
71860702 shares · 2025-12-31· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-17.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 9 of 11 periods available· newest 2023-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 11 of 11 periods available· newest 2025-12-31
Total assets: 10 of 11 periods available· newest 2025-12-31
Total liabilities: 10 of 11 periods available· newest 2025-12-31
Current assets: 10 of 11 periods available· newest 2025-12-31
Current liabilities: 10 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 10 of 11 periods available· newest 2025-12-31
Shares outstanding: 10 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+6.8%

Prior period

USD 361.37 million

2024-01-01 – 2024-12-31
Current period

USD 386.01 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

386013000 − 361374000 = 24639000 USD

361374000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
386013000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · SINOVAC BIOTECH LTD · 2025-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Year-over-year change in Revenue: 24639000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 386013000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm#5356766 Filing: 000119312526258534 Input fundies:Revenue: 361374000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm#5358580 Filing: 000119312526258534
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 455.29 million

Prior period

−USD 56.89 million

2024-01-01 – 2024-12-31
Current period

−USD 512.18 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-512184000 − -56891000 = -455293000 USD

-56891000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-512184000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SINOVAC BIOTECH LTD · 2025-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Year-over-year change in Operating cash flow: -455293000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -512184000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm#2907679 Filing: 000119312526258534 Input fundies:OperatingCashFlow: -56891000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm#2909621 Filing: 000119312526258534
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-49%

Prior period

USD 95.96 million

2024-01-01 – 2024-12-31
Current period

USD 48.92 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

48917000 − 95960000 = -47043000 USD

95960000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
48917000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · SINOVAC BIOTECH LTD · 2025-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Year-over-year change in Capital expenditure: -47043000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 48917000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm#2955764 Filing: 000119312526258534 Input fundies:CapitalExpenditure: 95960000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm#2957544 Filing: 000119312526258534
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Net income.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 386.01 million 100% of revenue
Cost of revenue USD 124.03 million 32% of revenue
Operating expenses USD 752.11 million 195% of revenue
Operating income −USD 490.13 million −127% of revenue
Tax, interest and other Derived Unavailable An input is unavailable.
Net income Unavailable An input is unavailable.

Cash

Operating cash flow −USD 512.18 million −133% of revenue
Capital expenditure USD 48.92 million 13% of revenue
Free cash flow Derived −USD 561.1 million −145% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Net loss: net income was −0.8% of revenue.
2017 15%11%74%
2018 9.5%10%80%
2019 18%9.6%72%
2020 22%21%58%
2021 42%49%9%
2022 Operating loss: operating costs were 135% of revenue.
2023 Operating loss: operating costs were 252% of revenue.
2024 Not shown: operating income or net income is not reported.
2025 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	72431000	71927000 Derived	504000	1100000 Derived	-596000	-26556000 Derived	Source 2016-01-01 – 2016-12-31: 72431000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: 504000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -596000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -13902000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 12654000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	174346000	128929000 Derived	45417000	19610000 Derived	25807000	47841000 Derived	Source 2017-01-01 – 2017-12-31: 174346000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: 45417000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: 25807000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: 59756000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 11915000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	229650000	184334000 Derived	45316000	23534000 Derived	21782000	2330000 Derived	Source 2018-01-01 – 2018-12-31: 229650000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: 45316000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: 21782000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: 7943000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 5613000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	246053000	177491000 Derived	68562000	23633000 Derived	44929000	28446000 Derived	Source 2019-01-01 – 2019-12-31: 246053000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: 68562000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: 44929000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: 39074000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 10628000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	510624000	294980000 Derived	215644000	105275000 Derived	110369000	351823000 Derived	Source 2020-01-01 – 2020-12-31: 510624000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 215644000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: 110369000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 479309000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 127486000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	19365354000	1746984000 Derived	17618370000	9496188000 Derived	8122182000	14727702000 Derived	Source 2021-01-01 – 2021-12-31: 19365354000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 17618370000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 8122182000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 15321913000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 594211000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	1473427000	1982412000 Derived	-508985000	-523452000 Derived	14467000	-1111973000 Derived	Source 2022-01-01 – 2022-12-31: 1473427000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -508985000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: 14467000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -798117000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 313856000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	470170000	1184153000 Derived	-713983000	-700492000 Derived	-13491000	-17520000 Derived	Source 2023-01-01 – 2023-12-31: 470170000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -713983000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -13491000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: 138645000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 156165000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	361374000	866909000 Derived	-505535000	Unavailable	Unavailable	-152851000 Derived	Source 2024-01-01 – 2024-12-31: 361374000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -505535000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -56891000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 95960000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	386013000	876143000 Derived	-490130000	Unavailable	Unavailable	-561101000 Derived	Source 2025-01-01 – 2025-12-31: 386013000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -490130000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -512184000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 48917000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 386M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	72431000	Revenue: 72431000 Open source
20172017-12-31	Revenue	174346000	Revenue: 174346000 Open source
20182018-12-31	Revenue	229650000	Revenue: 229650000 Open source
20192019-12-31	Revenue	246053000	Revenue: 246053000 Open source
20202020-12-31	Revenue	510624000	Revenue: 510624000 Open source
20212021-12-31	Revenue	19365354000	Revenue: 19365354000 Open source
20222022-12-31	Revenue	1473427000	Revenue: 1473427000 Open source
20232023-12-31	Revenue	470170000	Revenue: 470170000 Open source
20242024-12-31	Revenue	361374000	Revenue: 361374000 Open source
20252025-12-31	Revenue	386013000	Revenue: 386013000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

6.8% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	No prior comparable period	Revenue: 72431000 Open source
20172017-12-31	Year over year	140.7%	Revenue: 174346000 Open source Revenue: 72431000 Open source
20182018-12-31	Year over year	31.7%	Revenue: 229650000 Open source Revenue: 174346000 Open source
20192019-12-31	Year over year	7.1%	Revenue: 246053000 Open source Revenue: 229650000 Open source
20202020-12-31	Year over year	107.5%	Revenue: 510624000 Open source Revenue: 246053000 Open source
20212021-12-31	Year over year	3,692.5%	Revenue: 19365354000 Open source Revenue: 510624000 Open source
20222022-12-31	Year over year	-92.4%	Revenue: 1473427000 Open source Revenue: 19365354000 Open source
20232023-12-31	Year over year	-68.1%	Revenue: 470170000 Open source Revenue: 1473427000 Open source
20242024-12-31	Year over year	-23.1%	Revenue: 361374000 Open source Revenue: 470170000 Open source
20252025-12-31	Year over year	6.8%	Revenue: 386013000 Open source Revenue: 361374000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -127% 2025

Net margin -2.9% 2023

Free cash flow margin -145.4% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	0.7%	Operating Income: 504000 Open source Revenue: 72431000 Open source
20172017-12-31	Operating margin	26%	Operating Income: 45417000 Open source Revenue: 174346000 Open source
20182018-12-31	Operating margin	19.7%	Operating Income: 45316000 Open source Revenue: 229650000 Open source
20192019-12-31	Operating margin	27.9%	Operating Income: 68562000 Open source Revenue: 246053000 Open source
20202020-12-31	Operating margin	42.2%	Operating Income: 215644000 Open source Revenue: 510624000 Open source
20212021-12-31	Operating margin	91%	Operating Income: 17618370000 Open source Revenue: 19365354000 Open source
20222022-12-31	Operating margin	-34.5%	Operating Income: -508985000 Open source Revenue: 1473427000 Open source
20232023-12-31	Operating margin	-151.9%	Operating Income: -713983000 Open source Revenue: 470170000 Open source
20242024-12-31	Operating margin	-139.9%	Operating Income: -505535000 Open source Revenue: 361374000 Open source
20252025-12-31	Operating margin	-127%	Operating Income: -490130000 Open source Revenue: 386013000 Open source
20162016-12-31	Net margin	-0.8%	Net Income: -596000 Open source Revenue: 72431000 Open source
20172017-12-31	Net margin	14.8%	Net Income: 25807000 Open source Revenue: 174346000 Open source
20182018-12-31	Net margin	9.5%	Net Income: 21782000 Open source Revenue: 229650000 Open source
20192019-12-31	Net margin	18.3%	Net Income: 44929000 Open source Revenue: 246053000 Open source
20202020-12-31	Net margin	21.6%	Net Income: 110369000 Open source Revenue: 510624000 Open source
20212021-12-31	Net margin	41.9%	Net Income: 8122182000 Open source Revenue: 19365354000 Open source
20222022-12-31	Net margin	1%	Net Income: 14467000 Open source Revenue: 1473427000 Open source
20232023-12-31	Net margin	-2.9%	Net Income: -13491000 Open source Revenue: 470170000 Open source
2024-12-31	Net margin	Not reported	Revenue: 361374000 Open source
2025-12-31	Net margin	Not reported	Revenue: 386013000 Open source
20162016-12-31	Free cash flow margin	-36.7%	Revenue: 72431000 Open source Operating Cash Flow: -13902000 Open source Capital Expenditure: 12654000 Open source
20172017-12-31	Free cash flow margin	27.4%	Revenue: 174346000 Open source Operating Cash Flow: 59756000 Open source Capital Expenditure: 11915000 Open source
20182018-12-31	Free cash flow margin	1%	Revenue: 229650000 Open source Operating Cash Flow: 7943000 Open source Capital Expenditure: 5613000 Open source
20192019-12-31	Free cash flow margin	11.6%	Revenue: 246053000 Open source Operating Cash Flow: 39074000 Open source Capital Expenditure: 10628000 Open source
20202020-12-31	Free cash flow margin	68.9%	Revenue: 510624000 Open source Operating Cash Flow: 479309000 Open source Capital Expenditure: 127486000 Open source
20212021-12-31	Free cash flow margin	76.1%	Revenue: 19365354000 Open source Operating Cash Flow: 15321913000 Open source Capital Expenditure: 594211000 Open source
20222022-12-31	Free cash flow margin	-75.5%	Revenue: 1473427000 Open source Operating Cash Flow: -798117000 Open source Capital Expenditure: 313856000 Open source
20232023-12-31	Free cash flow margin	-3.7%	Revenue: 470170000 Open source Operating Cash Flow: 138645000 Open source Capital Expenditure: 156165000 Open source
20242024-12-31	Free cash flow margin	-42.3%	Revenue: 361374000 Open source Operating Cash Flow: -56891000 Open source Capital Expenditure: 95960000 Open source
20252025-12-31	Free cash flow margin	-145.4%	Revenue: 386013000 Open source Operating Cash Flow: -512184000 Open source Capital Expenditure: 48917000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -512.2M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-13902000	Operating Cash Flow: -13902000 Open source
20172017-12-31	Operating cash flow	59756000	Operating Cash Flow: 59756000 Open source
20182018-12-31	Operating cash flow	7943000	Operating Cash Flow: 7943000 Open source
20192019-12-31	Operating cash flow	39074000	Operating Cash Flow: 39074000 Open source
20202020-12-31	Operating cash flow	479309000	Operating Cash Flow: 479309000 Open source
20212021-12-31	Operating cash flow	15321913000	Operating Cash Flow: 15321913000 Open source
20222022-12-31	Operating cash flow	-798117000	Operating Cash Flow: -798117000 Open source
20232023-12-31	Operating cash flow	138645000	Operating Cash Flow: 138645000 Open source
20242024-12-31	Operating cash flow	-56891000	Operating Cash Flow: -56891000 Open source
20252025-12-31	Operating cash flow	-512184000	Operating Cash Flow: -512184000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -561.1M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	-26556000	Operating Cash Flow: -13902000 Open source Capital Expenditure: 12654000 Open source
20172017-12-31	Free cash flow	47841000	Operating Cash Flow: 59756000 Open source Capital Expenditure: 11915000 Open source
20182018-12-31	Free cash flow	2330000	Operating Cash Flow: 7943000 Open source Capital Expenditure: 5613000 Open source
20192019-12-31	Free cash flow	28446000	Operating Cash Flow: 39074000 Open source Capital Expenditure: 10628000 Open source
20202020-12-31	Free cash flow	351823000	Operating Cash Flow: 479309000 Open source Capital Expenditure: 127486000 Open source
20212021-12-31	Free cash flow	14727702000	Operating Cash Flow: 15321913000 Open source Capital Expenditure: 594211000 Open source
20222022-12-31	Free cash flow	-1111973000	Operating Cash Flow: -798117000 Open source Capital Expenditure: 313856000 Open source
20232023-12-31	Free cash flow	-17520000	Operating Cash Flow: 138645000 Open source Capital Expenditure: 156165000 Open source
20242024-12-31	Free cash flow	-152851000	Operating Cash Flow: -56891000 Open source Capital Expenditure: 95960000 Open source
20252025-12-31	Free cash flow	-561101000	Operating Cash Flow: -512184000 Open source Capital Expenditure: 48917000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

25.1% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	38.7%	Total Liabilities: 81689000 Open source Total Assets: 211355000 Open source
20172017-12-31	Liabilities / assets	40.8%	Total Liabilities: 122079000 Open source Total Assets: 299219000 Open source
20182018-12-31	Liabilities / assets	21.1%	Total Liabilities: 77852000 Open source Total Assets: 369780000 Open source
20192019-12-31	Liabilities / assets	22.1%	Total Liabilities: 100104000 Open source Total Assets: 452299000 Open source
20202020-12-31	Liabilities / assets	41.1%	Total Liabilities: 781201000 Open source Total Assets: 1901326000 Open source
20212021-12-31	Liabilities / assets	19.1%	Total Liabilities: 3205524000 Open source Total Assets: 16758694000 Open source
20222022-12-31	Liabilities / assets	12.7%	Total Liabilities: 1787247000 Open source Total Assets: 14030542000 Open source
20232023-12-31	Liabilities / assets	14.5%	Total Liabilities: 1969545000 Open source Total Assets: 13612020000 Open source
20242024-12-31	Liabilities / assets	16.6%	Total Liabilities: 2043851000 Open source Total Assets: 12337281000 Open source
20252025-12-31	Liabilities / assets	25.1%	Total Liabilities: 2145473000 Open source Total Assets: 8541725000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.59× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	1.97×	Current Assets: 130747000 Open source Current Liabilities: 66264000 Open source
20172017-12-31	Current assets / current liabilities	2.2×	Current Assets: 203888000 Open source Current Liabilities: 92543000 Open source
20182018-12-31	Current assets / current liabilities	4.88×	Current Assets: 284175000 Open source Current Liabilities: 58205000 Open source
20192019-12-31	Current assets / current liabilities	4.01×	Current Assets: 349607000 Open source Current Liabilities: 87199000 Open source
20202020-12-31	Current assets / current liabilities	2.3×	Current Assets: 1560293000 Open source Current Liabilities: 679610000 Open source
20212021-12-31	Current assets / current liabilities	5.93×	Current Assets: 14937755000 Open source Current Liabilities: 2518569000 Open source
20222022-12-31	Current assets / current liabilities	9×	Current Assets: 11304685000 Open source Current Liabilities: 1256401000 Open source
20232023-12-31	Current assets / current liabilities	8.97×	Current Assets: 11597299000 Open source Current Liabilities: 1292712000 Open source
20242024-12-31	Current assets / current liabilities	7.33×	Current Assets: 10644515000 Open source Current Liabilities: 1451898000 Open source
20252025-12-31	Current assets / current liabilities	4.59×	Current Assets: 7064498000 Open source Current Liabilities: 1540365000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 596,000 Exact value Exact value: -596000 USD 2016-01-01 – 2016-12-31: -596000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SINOVAC BIOTECH LTD · 2016-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Net Income: -596000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -596000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459019013766/sva-20181231.xml#3590763 Filing: 000156459019013766 The citation records this snapshot. The page link may show a newer release later.	−USD 13.9 million Exact value Exact value: -13902000 USD 2016-01-01 – 2016-12-31: -13902000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SINOVAC BIOTECH LTD · 2016-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Operating Cash Flow: -13902000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13902000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459019013766/sva-20181231.xml#363650 Filing: 000156459019013766 The citation records this snapshot. The page link may show a newer release later.	USD 12.65 million Exact value Exact value: 12654000 USD 2016-01-01 – 2016-12-31: 12654000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SINOVAC BIOTECH LTD · 2016-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Capital Expenditure: 12654000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12654000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459019013766/sva-20181231.xml#368546 Filing: 000156459019013766 The citation records this snapshot. The page link may show a newer release later.	−USD 26.56 million Calculation and evidence -13902000 − 12654000 USD Exact free cash flow: -26556000 USD 2016-01-01 – 2016-12-31: -13902000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 12654000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SINOVAC BIOTECH LTD · 2016-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Free cash flow: -26556000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13902000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459019013766/sva-20181231.xml#363650 Filing: 000156459019013766 Input fundies:CapitalExpenditure: 12654000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459019013766/sva-20181231.xml#368546 Filing: 000156459019013766 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	USD 25.81 million Exact value Exact value: 25807000 USD 2017-01-01 – 2017-12-31: 25807000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SINOVAC BIOTECH LTD · 2017-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Net Income: 25807000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: 25807000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459020020204/sva-20191231.xml#254862 Filing: 000156459020020204 The citation records this snapshot. The page link may show a newer release later.	USD 59.76 million Exact value Exact value: 59756000 USD 2017-01-01 – 2017-12-31: 59756000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SINOVAC BIOTECH LTD · 2017-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Operating Cash Flow: 59756000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 59756000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459020020204/sva-20191231.xml#350731 Filing: 000156459020020204 The citation records this snapshot. The page link may show a newer release later.	USD 11.92 million Exact value Exact value: 11915000 USD 2017-01-01 – 2017-12-31: 11915000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SINOVAC BIOTECH LTD · 2017-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Capital Expenditure: 11915000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11915000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459020020204/sva-20191231.xml#357364 Filing: 000156459020020204 The citation records this snapshot. The page link may show a newer release later.	USD 47.84 million Calculation and evidence 59756000 − 11915000 USD Exact free cash flow: 47841000 USD 2017-01-01 – 2017-12-31: 59756000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 11915000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SINOVAC BIOTECH LTD · 2017-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Free cash flow: 47841000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 59756000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459020020204/sva-20191231.xml#350731 Filing: 000156459020020204 Input fundies:CapitalExpenditure: 11915000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459020020204/sva-20191231.xml#357364 Filing: 000156459020020204 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	USD 21.78 million Exact value Exact value: 21782000 USD 2018-01-01 – 2018-12-31: 21782000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SINOVAC BIOTECH LTD · 2018-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Net Income: 21782000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: 21782000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459021020156/sva-20f_20201231.htm#5429812 Filing: 000156459021020156 The citation records this snapshot. The page link may show a newer release later.	USD 7.94 million Exact value Exact value: 7943000 USD 2018-01-01 – 2018-12-31: 7943000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SINOVAC BIOTECH LTD · 2018-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Operating Cash Flow: 7943000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 7943000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459021020156/sva-20f_20201231.htm#4167734 Filing: 000156459021020156 The citation records this snapshot. The page link may show a newer release later.	USD 5.61 million Exact value Exact value: 5613000 USD 2018-01-01 – 2018-12-31: 5613000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SINOVAC BIOTECH LTD · 2018-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Capital Expenditure: 5613000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5613000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459021020156/sva-20f_20201231.htm#4253608 Filing: 000156459021020156 The citation records this snapshot. The page link may show a newer release later.	USD 2.33 million Calculation and evidence 7943000 − 5613000 USD Exact free cash flow: 2330000 USD 2018-01-01 – 2018-12-31: 7943000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 5613000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SINOVAC BIOTECH LTD · 2018-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Free cash flow: 2330000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 7943000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459021020156/sva-20f_20201231.htm#4167734 Filing: 000156459021020156 Input fundies:CapitalExpenditure: 5613000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459021020156/sva-20f_20201231.htm#4253608 Filing: 000156459021020156 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	USD 44.93 million Exact value Exact value: 44929000 USD 2019-01-01 – 2019-12-31: 44929000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SINOVAC BIOTECH LTD · 2019-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Net Income: 44929000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: 44929000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459022016857/sva-20f_20211231.htm#4974357 Filing: 000156459022016857 The citation records this snapshot. The page link may show a newer release later.	USD 39.07 million Exact value Exact value: 39074000 USD 2019-01-01 – 2019-12-31: 39074000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SINOVAC BIOTECH LTD · 2019-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Operating Cash Flow: 39074000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 39074000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459022016857/sva-20f_20211231.htm#3597330 Filing: 000156459022016857 The citation records this snapshot. The page link may show a newer release later.	USD 10.63 million Exact value Exact value: 10628000 USD 2019-01-01 – 2019-12-31: 10628000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SINOVAC BIOTECH LTD · 2019-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Capital Expenditure: 10628000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10628000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459022016857/sva-20f_20211231.htm#3688957 Filing: 000156459022016857 The citation records this snapshot. The page link may show a newer release later.	USD 28.45 million Calculation and evidence 39074000 − 10628000 USD Exact free cash flow: 28446000 USD 2019-01-01 – 2019-12-31: 39074000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 10628000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SINOVAC BIOTECH LTD · 2019-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Free cash flow: 28446000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 39074000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459022016857/sva-20f_20211231.htm#3597330 Filing: 000156459022016857 Input fundies:CapitalExpenditure: 10628000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459022016857/sva-20f_20211231.htm#3688957 Filing: 000156459022016857 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	USD 110.37 million Exact value Exact value: 110369000 USD 2020-01-01 – 2020-12-31: 110369000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SINOVAC BIOTECH LTD · 2020-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Net Income: 110369000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: 110369000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000095017023015997/sva-20221231.htm#5757927 Filing: 000095017023015997 The citation records this snapshot. The page link may show a newer release later.	USD 479.31 million Exact value Exact value: 479309000 USD 2020-01-01 – 2020-12-31: 479309000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SINOVAC BIOTECH LTD · 2020-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Operating Cash Flow: 479309000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 479309000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000095017023015997/sva-20221231.htm#4128975 Filing: 000095017023015997 The citation records this snapshot. The page link may show a newer release later.	USD 127.49 million Exact value Exact value: 127486000 USD 2020-01-01 – 2020-12-31: 127486000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SINOVAC BIOTECH LTD · 2020-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Capital Expenditure: 127486000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 127486000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459022016857/sva-20f_20211231.htm#3687163 Filing: 000156459022016857 The citation records this snapshot. The page link may show a newer release later.	USD 351.82 million Calculation and evidence 479309000 − 127486000 USD Exact free cash flow: 351823000 USD 2020-01-01 – 2020-12-31: 479309000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 127486000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SINOVAC BIOTECH LTD · 2020-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Free cash flow: 351823000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 479309000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000095017023015997/sva-20221231.htm#4128975 Filing: 000095017023015997 Input fundies:CapitalExpenditure: 127486000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000156459022016857/sva-20f_20211231.htm#3687163 Filing: 000156459022016857 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	USD 8.12 billion Exact value Exact value: 8122182000 USD 2021-01-01 – 2021-12-31: 8122182000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SINOVAC BIOTECH LTD · 2021-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Net Income: 8122182000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 8122182000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526194394/sva-20241231.htm#6007303 Filing: 000119312526194394 The citation records this snapshot. The page link may show a newer release later.	USD 15.32 billion Exact value Exact value: 15321913000 USD 2021-01-01 – 2021-12-31: 15321913000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SINOVAC BIOTECH LTD · 2021-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Operating Cash Flow: 15321913000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 15321913000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526194394/sva-20241231.htm#6125736 Filing: 000119312526194394 The citation records this snapshot. The page link may show a newer release later.	USD 594.21 million Exact value Exact value: 594211000 USD 2021-01-01 – 2021-12-31: 594211000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SINOVAC BIOTECH LTD · 2021-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Capital Expenditure: 594211000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 594211000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526194394/sva-20241231.htm#3981638 Filing: 000119312526194394 The citation records this snapshot. The page link may show a newer release later.	USD 14.73 billion Calculation and evidence 15321913000 − 594211000 USD Exact free cash flow: 14727702000 USD 2021-01-01 – 2021-12-31: 15321913000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 594211000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SINOVAC BIOTECH LTD · 2021-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Free cash flow: 14727702000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 15321913000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526194394/sva-20241231.htm#6125736 Filing: 000119312526194394 Input fundies:CapitalExpenditure: 594211000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526194394/sva-20241231.htm#3981638 Filing: 000119312526194394 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	USD 14.47 million Exact value Exact value: 14467000 USD 2022-01-01 – 2022-12-31: 14467000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SINOVAC BIOTECH LTD · 2022-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Net Income: 14467000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: 14467000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526194394/sva-20241231.htm#5332913 Filing: 000119312526194394 The citation records this snapshot. The page link may show a newer release later.	−USD 798.12 million Exact value Exact value: -798117000 USD 2022-01-01 – 2022-12-31: -798117000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SINOVAC BIOTECH LTD · 2022-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Operating Cash Flow: -798117000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -798117000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526194394/sva-20241231.htm#5460136 Filing: 000119312526194394 The citation records this snapshot. The page link may show a newer release later.	USD 313.86 million Exact value Exact value: 313856000 USD 2022-01-01 – 2022-12-31: 313856000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SINOVAC BIOTECH LTD · 2022-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Capital Expenditure: 313856000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 313856000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526194394/sva-20241231.htm#3979857 Filing: 000119312526194394 The citation records this snapshot. The page link may show a newer release later.	−USD 1.11 billion Calculation and evidence -798117000 − 313856000 USD Exact free cash flow: -1111973000 USD 2022-01-01 – 2022-12-31: -798117000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 313856000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SINOVAC BIOTECH LTD · 2022-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Free cash flow: -1111973000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -798117000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526194394/sva-20241231.htm#5460136 Filing: 000119312526194394 Input fundies:CapitalExpenditure: 313856000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526194394/sva-20241231.htm#3979857 Filing: 000119312526194394 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 13.49 million Exact value Exact value: -13491000 USD 2023-01-01 – 2023-12-31: -13491000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SINOVAC BIOTECH LTD · 2023-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Net Income: -13491000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13491000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526194394/sva-20241231.htm#4667918 Filing: 000119312526194394 The citation records this snapshot. The page link may show a newer release later.	USD 138.65 million Exact value Exact value: 138645000 USD 2023-01-01 – 2023-12-31: 138645000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SINOVAC BIOTECH LTD · 2023-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Operating Cash Flow: 138645000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 138645000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm#2911431 Filing: 000119312526258534 The citation records this snapshot. The page link may show a newer release later.	USD 156.17 million Exact value Exact value: 156165000 USD 2023-01-01 – 2023-12-31: 156165000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SINOVAC BIOTECH LTD · 2023-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Capital Expenditure: 156165000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 156165000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm#2959324 Filing: 000119312526258534 The citation records this snapshot. The page link may show a newer release later.	−USD 17.52 million Calculation and evidence 138645000 − 156165000 USD Exact free cash flow: -17520000 USD 2023-01-01 – 2023-12-31: 138645000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 156165000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SINOVAC BIOTECH LTD · 2023-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Free cash flow: -17520000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 138645000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm#2911431 Filing: 000119312526258534 Input fundies:CapitalExpenditure: 156165000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm#2959324 Filing: 000119312526258534 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	Unavailable Not reported for this period.	−USD 56.89 million Exact value Exact value: -56891000 USD 2024-01-01 – 2024-12-31: -56891000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SINOVAC BIOTECH LTD · 2024-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Operating Cash Flow: -56891000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -56891000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm#2909621 Filing: 000119312526258534 The citation records this snapshot. The page link may show a newer release later.	USD 95.96 million Exact value Exact value: 95960000 USD 2024-01-01 – 2024-12-31: 95960000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SINOVAC BIOTECH LTD · 2024-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Capital Expenditure: 95960000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 95960000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm#2957544 Filing: 000119312526258534 The citation records this snapshot. The page link may show a newer release later.	−USD 152.85 million Calculation and evidence -56891000 − 95960000 USD Exact free cash flow: -152851000 USD 2024-01-01 – 2024-12-31: -56891000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 95960000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SINOVAC BIOTECH LTD · 2024-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Free cash flow: -152851000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -56891000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm#2909621 Filing: 000119312526258534 Input fundies:CapitalExpenditure: 95960000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm#2957544 Filing: 000119312526258534 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	Unavailable Not reported for this period.	−USD 512.18 million Exact value Exact value: -512184000 USD 2025-01-01 – 2025-12-31: -512184000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SINOVAC BIOTECH LTD · 2025-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Operating Cash Flow: -512184000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -512184000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm#2907679 Filing: 000119312526258534 The citation records this snapshot. The page link may show a newer release later.	USD 48.92 million Exact value Exact value: 48917000 USD 2025-01-01 – 2025-12-31: 48917000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SINOVAC BIOTECH LTD · 2025-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Capital Expenditure: 48917000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 48917000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm#2955764 Filing: 000119312526258534 The citation records this snapshot. The page link may show a newer release later.	−USD 561.1 million Calculation and evidence -512184000 − 48917000 USD Exact free cash flow: -561101000 USD 2025-01-01 – 2025-12-31: -512184000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 48917000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SINOVAC BIOTECH LTD · 2025-12-31 SINOVAC BIOTECH LTD (edgar:1084201) Free cash flow: -561101000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1084201?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -512184000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm#2907679 Filing: 000119312526258534 Input fundies:CapitalExpenditure: 48917000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm#2955764 Filing: 000119312526258534 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

266 filings · 1,299 latest values · 1,299 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001084201, 1084201, SVA, edgar:1084201

Also known as NET FORCE SYSTEMS INC, SINOVAC BIOTECH LTD

SINOVAC BIOTECH LTD

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation